Dr. Khandwalla is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
250 N Robertson Blvd
Ste 403
Beverly Hills, CA 90211Phone+1 310-385-3496Fax+1 310-967-1800
Education & Training
- MedStar Health/Georgetown-Washington Hospital CenterFellowship, Cardiovascular Disease, 2009 - 2012
- NYU Grossman School of MedicineResidency, Internal Medicine, 2005 - 2008
- Tufts University School of MedicineClass of 2005
Certifications & Licensure
- CA State Medical License 2012 - 2025
- DC State Medical License 2009 - 2013
- NY State Medical License 2008 - 2010
- American Board of Internal Medicine Cardiovascular Disease
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
- Fellow (FACC) American College of Cardiology
Publications & Presentations
PubMed
- 4 citationsSleep Outcomes From AWAKE-HF: A Randomized Clinical Trial of Sacubitril/Valsartan vs Enalapril in Patients With Heart Failure and Reduced Ejection Fraction.Robert L. Owens, Kade Birkeland, J. Thomas Heywood, Steven R. Steinhubl, Jonas F. Dorn
Journal of Cardiac Failure. 2021-08-21 - 16 citationsThe AWAKE-HF Study: Sacubitril/Valsartan Impact on Daily Physical Activity and Sleep in Heart FailureRaj M. Khandwalla, Daniel Grant, Kade Birkeland, J. Thomas Heywood, Emmanuel Fombu
American Journal of Cardiovascular Drugs. 2021-03-01 - 2 citationsActivity Sensors to Evaluate the Effect of Sacubitril/Valsartan on Quality-of-Life in Heart Failure: rational and design of the AWAKE-HF study.Raj M. Khandwalla, Kade Birkeland, J. Thomas Heywood, Steven R. Steinhubl, Kevin McCague
ESC Heart Failure. 2019-12-01
Abstracts/Posters
- [Board 519] Sleep Outcomes From AWAKE-HF a Randomized Clinical Trial With Open-Label Extension of Sacubitril/Valsartan Versus Enalapril in Patients With Heart Failure...Raj Khandwalla, 2019 ACC Scientific Session & Expo, New Orleans, New Orleans, 3/17/2019
- [Board 518] Sacubitril/Valsartan Versus Enalapril in Patients With Heart Failure With Reduced Ejection Fraction: Findings From AWAKE-HF a Randomized Clinical Trial U...Raj Khandwalla, 2019 ACC Scientific Session & Expo, New Orleans, New Orleans, 3/17/2019
Press Mentions
- Cardiologists Share Tips on Managing Heart Conditions in Primary CareMarch 31st, 2022
- Does Paleo Diet Raise Cloresterol?March 15th, 2022
- Innovative Medical Devices Help Healthcare Systems Become More EfficientAugust 19th, 2020
- Join now to see all
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: